Retatrutide 15mg

Quickstart Highlights

Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors[1], studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes[2][3]. With an extended half-life of approximately 6 days, this peptide enables convenient once-weekly subcutaneous dosing with a gradual titration protocol to optimize tolerability[1][4].

Reconstitute: Add 1.2 mL bacteriostatic water → 10 mg/mL concentration (ideal for all weekly doses).
Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 0.1 mg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing

Standard / Gradual Titration Approach (1.2 mL = 10 mg/mL)

Week(s)	Weekly Dose (mg)	Units (mL)
Weeks 1–4	2 mg	20 units (0.20 mL)
Weeks 5–8	4 mg	40 units (0.40 mL)
Weeks 9–12	8 mg	80 units (0.80 mL)
Weeks 13+	12 mg	120 units (1.20 mL)

Frequency: Inject once weekly subcutaneously. This schedule follows clinical trial protocols that demonstrated significant weight loss (up to 24% at 48 weeks with 12 mg weekly)[2] while minimizing gastrointestinal adverse events through gradual escalation[1][4]. Starting at 2 mg weekly (versus 4 mg) significantly reduces initial GI side effects. For doses exceeding 1.0 mL, either reconstitute a second vial or split the dose into multiple injection sites.

Reconstitution Steps

Reference-derived details for Retatrutide 15mg.

Draw 1.2 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on a 12–48 week weekly protocol with gradual titration to maintenance dose.

Peptide Vials (Retatrutide, 12 mg each): Requirements increase with dose escalation
Peptide Vials (Retatrutide, 12 mg each): Requirements increase with dose escalation: 12 weeks (2→4→8 mg titration): ~5 vials
Peptide Vials (Retatrutide, 12 mg each): Requirements increase with dose escalation: 24 weeks (up to 12 mg): ~17 vials
Peptide Vials (Retatrutide, 12 mg each): Requirements increase with dose escalation: 48 weeks (maintenance at 12 mg): ~41 vials
Insulin Syringes (U-100, 1 mL):
Insulin Syringes (U-100, 1 mL):: Per week: 1 syringe (once-weekly dosing)
Insulin Syringes (U-100, 1 mL):: 12 weeks: 12 syringes
Insulin Syringes (U-100, 1 mL):: 24 weeks: 24 syringes
Insulin Syringes (U-100, 1 mL):: 48 weeks: 48 syringes
Bacteriostatic Water (10 mL bottles): Use 1.2 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use 1.2 mL per vial for reconstitution.: 12 weeks (5 vials): 6 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use 1.2 mL per vial for reconstitution.: 24 weeks (17 vials): 20.4 mL → 3 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use 1.2 mL per vial for reconstitution.: 48 weeks (41 vials): 49.2 mL → 5 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week.
Alcohol Swabs: One for the vial stopper + one for the injection site each week.: Per week: 2 swabs
Alcohol Swabs: One for the vial stopper + one for the injection site each week.: 12 weeks: 24 swabs → 1 × 100-count box
Alcohol Swabs: One for the vial stopper + one for the injection site each week.: 24 weeks: 48 swabs → 1 × 100-count box
Alcohol Swabs: One for the vial stopper + one for the injection site each week.: 48 weeks: 96 swabs → 1 × 100-count box

Protocol Overview

Concise summary of the once-weekly regimen based on clinical trial protocols.

Goal: Achieve substantial weight loss (up to 24% of body weight) and improved metabolic parameters through triple receptor agonism[2][5]. Open source
Schedule: Weekly subcutaneous injections for 12+ weeks with gradual dose escalation.
Dose Range: 2–12 mg once weekly; clinical trials tested up to 12 mg as the maximum maintenance dose[1][3]. Open source
Reconstitution: 1.2 mL per 12 mg vial (10 mg/mL) provides excellent concentration for convenient weekly dosing.
Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted solution refrigerated at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.

Dosing Protocol

Evidence-based weekly titration approach from clinical trials.

Start: 2 mg once weekly for first 4 weeks to establish tolerability[1][4]. Open source
Escalation: Increase to 4 mg weekly (Weeks 5–8), then 8 mg weekly (Weeks 9–12)[1]. Open source
Maintenance: 12 mg weekly (Week 13 onward) for maximum efficacy; 8 mg weekly is an alternative maintenance dose[2]. Open source
Frequency: Once per week (subcutaneous); consistent day/time recommended.
Cycle Length: Minimum 12 weeks for titration; clinical trials extended to 48 weeks showing sustained weight loss[2]. Open source
Timing: Any consistent weekly schedule; rotate injection sites each week.

Storage Instructions

Proper storage maintains peptide stability and potency.

Lyophilized: Store at −20 °C (−4 °F) or colder for long-term preservation; protect from moisture and light[11][12]. Open source
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) immediately after mixing; use within 2–4 weeks for maximum potency[11]. Open source
Handling: Allow frozen vials to reach room temperature before opening to minimize condensation; never expose reconstituted solution to heat or direct sunlight.
Aliquoting: For extended storage beyond 4 weeks, consider freezing unused aliquots; avoid repeated freeze-thaw cycles[12]. Open source

Important Notes

Practical considerations for safe and effective weekly administration.

Weekly consistency: Choose a specific day/time for your weekly injection and maintain this schedule throughout the protocol.
Gradual titration is essential: Starting at 2 mg weekly (versus higher doses) significantly reduces initial gastrointestinal side effects[4]. Open source
Use new sterile insulin syringes for each injection; dispose immediately in a puncture-proof sharps container[14]. Open source
Rotate injection sites weekly (abdomen, thighs, upper arms) at least 1 inch apart to prevent local irritation or lipohypertrophy[15]. Open source
At 10 mg/mL concentration, all doses up to 12 mg fit within 1.2 mL—no split injections required with a standard 1.5 mL or 3 mL syringe.
Monitor for gastrointestinal side effects (nausea, diarrhea); if severe, consider extending the time at current dose before escalating.

Lifestyle Factors

Complementary strategies to optimize outcomes during retatrutide protocols.

Nutrition: Adopt a balanced, protein-forward diet (1.0–1.2 g/kg body weight) to preserve lean mass during weight loss[10]. Open source
Hydration: Maintain adequate fluid intake, especially during dose titration when GI effects are most common.
Physical activity: Combine resistance training (2–3×/week) with moderate aerobic exercise to support metabolic adaptations and preserve muscle mass.
Sleep & stress: Prioritize 7–9 hours of quality sleep and implement stress management techniques to support hormonal balance and adherence.
Meal timing: Some individuals find smaller, more frequent meals help manage GI side effects during initial titration.

Potential Benefits & Side Effects

Observations from phase 2 and phase 3 clinical trials in humans.

Substantial weight loss: Up to 24% reduction in body weight at 48 weeks with 12 mg weekly dosing[2]. Open source
Glycemic improvement: Significant HbA1c reductions (approximately 2.0%) in adults with type 2 diabetes[3]. Open source
Metabolic benefits: Improvements in lipid profiles, blood pressure, and cardiovascular risk markers[1][5]. Open source
Convenient dosing: Once-weekly subcutaneous administration improves adherence compared to daily regimens[1]. Open source
Gastrointestinal effects: Nausea, diarrhea, vomiting, and constipation are the most common adverse events; typically mild-to-moderate and diminish over time[2][4]. Open source
Starting at 2 mg weekly (versus 4 mg) significantly reduces initial GI adverse events[4]. Open source
Injection site reactions: Mild redness, swelling, or discomfort at injection sites may occur; rotate sites to minimize.
Overall safety profile: Meta-analysis found no significant increase in overall adverse events compared to placebo[6][7]. Open source

Injection Technique

Subcutaneous injection guidelines based on clinical best practices and CDC recommendations[13][14].

Wash hands thoroughly with soap and water[14]. Open source
Clean the vial stopper with an alcohol swab and allow to air dry.
Select injection site (abdomen, thigh, or upper arm) and clean with a fresh alcohol swab; allow to dry completely[13]. Open source
Draw prescribed dose carefully; check for air bubbles and expel if present.
Pinch a skinfold of approximately 1 inch between thumb and forefinger[15]. Open source
Insert needle at a 90-degree angle (45-degree if subcutaneous fat layer is thin) into the pinched skin[13][14]. Open source
Do not aspirate for subcutaneous injections (aspiration is not required and may increase discomfort)[13]. Open source
Inject slowly and steadily; depress plunger completely.
Withdraw needle straight out and apply gentle pressure with clean gauze if needed.
Dispose of used syringe immediately in a puncture-proof sharps container; never recap needles[14]. Open source
Return reconstituted vial to refrigerator promptly.
Rotate injection sites weekly (at least 1 inch apart) to prevent lipohypertrophy[15]. Open source
Monitor for excessive redness, swelling, or signs of infection at injection site.

Recommended Source

We recommend Prime Lab Peptides for high-purity Retatrutide (12 mg vials).

Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.
Product ID: Retatrutide 12mg
Shop at Prime Lab Peptides

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References